A charitable organization founded in 2008 by a community of individuals affected by Pseudomyxoma Peritonei (PMP) and related Peritoneal Surface Malignancies (PSM). (cancerindex.org)
Ovarian1
In the present report, we describe a rare case of primary signet ring cell carcinoma of the appendix with ovarian metastasesand unresectable peritoneal dissemination occurring in a 45-year-old female patient. (wjgnet.com)
Pseudomyxoma peritonei10
The first recommendation would have been to biopsy 1 of these nodules at the time of surgery to rule out a disseminated peritoneal adenomucinosis or pseudomyxoma peritonei. (medscape.com)
Complete cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is the only curative treatment for pseudomyxoma peritonei (PMP) arising from the appendix. (biomedcentral.com)
4. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). (nih.gov)
6. Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis. (nih.gov)
7. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. (nih.gov)
9. Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. (nih.gov)
10. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience. (nih.gov)
11. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours. (nih.gov)
12. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. (nih.gov)
14. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei. (nih.gov)
Mucinous carcinomatosis1
3. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. (nih.gov)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy2
15. The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC). (nih.gov)
Treatment included staged therapeutic tumor debulking and right salpingo-oophorectomy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). (bvsalud.org)
Carcinomatosis3
At the time of surgery to close a colostomy, a disseminated peritoneal carcinomatosis was noted with no evidence of disseminated disease to other organs. (medscape.com)
High peritoneal carcinomatosis index (PCI) is associated with an increased risk of surgical complications. (biomedcentral.com)
8. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. (nih.gov)
DPAM1
Diffuse peritoneal adenomucinosis (DPAM) variant of PMP arising from a ruptured ovarian primary MCT after malignant transformation to a low-grade appendiceal-like mucinous neoplasm was ultimately confirmed. (bvsalud.org)
Complete cytoreductive surgery1
The introduction of complete cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) has dramatically improved outcomes for patients with PMP [ 5 ]. (biomedcentral.com)
Oxaliplatin1
I would recommend 6 cycles of oxaliplatin, leucovorin, and infusional 5-FU (FOLFOX) chemotherapy and periodic (eg, every 2-3 months) follow-up with CT scan and CEA levels until evidence of progressive disease. (medscape.com)
Cancer1
The peritoneal cancer index (PCI) [ 8 ] is a quantitative measure that describes the extent of peritoneal disease at surgery. (biomedcentral.com)
Survival1
In addition, the fact that chemotherapy has demonstrated increased survival and quality of life in this disease would favor commencement of treatment at this time. (medscape.com)
Peritoneum2
Two of 4 lymph nodes were positive, there was serosal extension, and approximately 6 peritoneal implants were noted locally in the sigmoid peritoneum. (medscape.com)
Tumor nodules in the peritoneum were resected and the patient was treated with several cycles of irinotecan-based and capecitabine chemotherapy. (medscape.com)
Surgery1
However, during surgery to reanastomose his colostomy, several hundred small peritoneal implants were noted (95% were 2-3 mm in size), mostly in the upper abdominal quadrants. (medscape.com)
Disease2
It is clear that the patient has developed progressive disease while on chemotherapy even though the CEA levels had normalized. (medscape.com)
Due to the more indolent nature of low-grade PMP compared to other peritoneal malignancies, our group has developed a two-step surgical approach for the curative treatment of patients with very high PCI in order to decrease the morbidity and mortality associated with the procedure and to offer a better alternative than debulking alone to patients with unresectable disease. (biomedcentral.com)